Momenta/Sandoz Tie-Up Adds Momentum to Large Molecules
This article was originally published in Start Up
Executive Summary
The July 2006 alliance between Momenta Pharmaceuticals and Novartis AG's generics outfit Sandoz underscores the role sugar characterization technologies may play in both copying complex molecules like follow-on biologics and improving on existing glycoproteins and complex mixtures.